Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity

This publication has 25 references indexed in Scilit:

• Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
  The Lancet, 2003
• The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials
  The American Journal of Medicine, 2002
• The Impact of Chronic Obstructive Pulmonary Disease on Work Loss in the United States
  American Journal of Respiratory and Critical Care Medicine, 2002
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
  American Journal of Respiratory and Critical Care Medicine, 2001
• Burden of Disease—Implications for Future Research
  JAMA, 2001
• Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 2000
• Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
  BMJ, 2000
• The Impact of COPD on Lung Health Worldwide
  Chest, 2000
• Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study
  Published by Elsevier ,1997
• Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1
  JAMA, 1994